Olanzapine-induced weight gain in the rat: Role of 5-HT2C and histamine H1 receptors

Psychopharmacology

Volumn 207, Issue 1, 2009, Pages 119-125

  Kirk, Shona L ^a   Glazebrook, John ^b   Grayson, Ben ^b   Neill, Joanna C ^b   Reynolds, Gavin P ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

5 HT2C receptor; Antipsychotic drug; Histamine H1 receptor; Olanzapine; Rat; Weight gain

Indexed keywords

5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL] 6 TRIFLUOROMETHYLINDOLINE; HALOPERIDOL; HISTAMINE H1 RECEPTOR; MEPYRAMINE MALEATE; OLANZAPINE; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; DRUG EFFECT; EXPERIMENTAL STUDY; FEMALE; INVERSE AGONISM; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; WEIGHT GAIN;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BENZODIAZEPINES; DOPAMINE ANTAGONISTS; DRUG INTERACTIONS; FEMALE; HALOPERIDOL; HISTAMINE H1 ANTAGONISTS; INDOLES; PYRIDINES; PYRILAMINE; RATS; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, HISTAMINE H1; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; WEIGHT GAIN;

EID: 70350302904     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1639-8     Document Type: Article

References (38)

1. VL Albaugh CR Henry NT Bello A Hajnal SL Lynch B Halle CJ Lynch 2006 Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents Obesity (Silver Spring) 14 36 51 10.1038/oby.2006.6 1:CAS:528:DC%2BD28XjvFWjsr4%3D
2. DB Allison JL Mentore M Heo LP Chandler JC Cappelleri MC Infante PJ Weiden 1999 Antipsychotic-induced weight gain: a comprehensive research synthesis Am J Psychiatry 156 1686 1696 1:STN:280:DC%2BD3c%2FhvFWmug%3D%3D 10553730
3. T Baptista M Parada L Hernandez 1987 Long term administration of some antipsychotic drugs increases body weight and feeding in rats. Are D2 dopamine receptors involved? Pharmacol Biochem Behav 27 399 405 10.1016/0091-3057(87) 90340-6 1:CAS:528:DyaL2sXlsVOitb0%3D 2889218 (Pubitemid 17107006)
4. KA Berg S Navailles TA Sanchez YM Silva MD Wood U Spampinato WP Clarke 2006 Differential effects of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxyl]-5- pyridyl]carbamoyl]-6-trifluoromethylindone (SB 243213) on 5- hydroxytryptamine(2C) receptor-mediated responses J Pharmacol Exp Ther 319 260 268 10.1124/jpet.106.104448 1:CAS:528:DC%2BD28XhtVCksL3E 16807362 (Pubitemid 44455131)
5. DW Bonhaus KK Weinhardt M Taylor A DeSouza PM McNeeley K Szczepanski DJ Fontana J Trinh CL Rocha MW Dawson LA Flippin RM Eglen 1997 RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist Neuropharmacology 36 621 629 10.1016/S0028-3908(97)00049-X 1:CAS:528:DyaK2sXktlSlsbs%3D 9225287 (Pubitemid 27272107)
6. PG Clifton MD Lee CT Dourish 2000 Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist and d-fenfluramine on feeding patterns in the rat Psychopharmacology (Berl) 152 256 267 10.1007/s002130000504 1:CAS:528:DC%2BD3cXosVKrs74%3D (Pubitemid 30822225)
7. SJ Cooper HA Al-Naser 2006 Dopaminergic control of food choice: contrasting effects of SKF 38393 and quinpirole on high-palatability food preference in the rat Neuropharmacology 50 953 963 10.1016/j.neuropharm.2006.01. 006 1:CAS:528:DC%2BD28XltlKrtbw%3D 16549074 (Pubitemid 44208835)
8. GD Cooper LC Pickavance JP Wilding JC Halford AJ Goudie 2005 A parametric analysis of olanzapine-induced weight gain in female rats Psychopharmacology (Berl) 181 80 89 10.1007/s00213-005-2224-4 1:CAS:528:DC%2BD2MXhtFWmt73N (Pubitemid 41440918)
9. GD Cooper LC Pickavance JP Wilding JA Harrold G Halford AJ Goudie 2007 Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities J Psychopharmacol 21 405 413 10.1177/0269881106069637 1:CAS:528:DC%2BD2sXptFGqu7o%3D 17050655 (Pubitemid 47077303)
10. N Davoodi M Kalinichev PG Clifton 2008 Comparative effects of olanzapine and ziprasidone on hypophagia induced by enhanced histamine neurotransmission in the rat Behav Pharmacol 19 121 128 10.1097/FBP.0b013e3282f62c66 1:CAS:528:DC%2BD1cXjtVektLo%3D 18332676
11. MJ Fell KM Marshall J Williams JC Neill 2004 Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats J Psychopharmacol 18 149 155 10.1177/0269881104042613 1:CAS:528: DC%2BD2cXms1ahtb4%3D 15260902 (Pubitemid 38954901)
12. MJ Fell JC Neill KM Marshall 2004 Effects of the classical antipsychotic haloperidol and atypical antipsychotic risperidone on weight gain, the oestrous cycle and uterine weight in female rats Eur Neuropsychopharmacol 14 385 392 10.1016/j.euroneuro.2003.12.001 1:CAS:528:DC%2BD2cXntFWrt7Y%3D 15336300 (Pubitemid 39141681)
13. MJ Fell N Anjum K Dickinson KM Marshall LM Peltola S Vickers S Cheetham JC Neill 2007 The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats Psychopharmacology (Berl) 194 221 231 10.1007/s00213-007-0833-9 1:CAS:528:DC%2BD2sXhtVKrs7nM (Pubitemid 47457949)
14. K Fukagawa T Sakata T Shiraishi H Yoshimatsu K Fujimoto K Ookuma H Wada 1989 Neuronal histamine modulates feeding behavior through H1-receptor in rat hypothalamus Am J Physiol 256 R605 611 1:CAS:528:DyaL1MXhs1Klsbk%3D 2564258
15. DB Gilbert SJ Cooper 1985 Analysis of dopamine D1 and D2 receptor involvement in d- and l-amphetamine-induced anorexia in rats Brain Res Bull 15 385 389 10.1016/0361-9230(85)90006-1 1:CAS:528:DyaL28XmtVw%3D 2933127 (Pubitemid 16223124)
16. M Han C Deng TH Burne KA Newell XF Huang 2008 Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression Psychoneuroendocrinology 33 569 580 10.1016/j.psyneuen.2008.01.018 1:CAS:528:DC%2BD1cXlslWitr0%3D 18358632
17. AW Hartfield NA Moore PG Clifton 2003 Serotonergic and histaminergic mechanisms involved in intralipid drinking? Pharmacol Biochem Behav 76 251 258 10.1016/S0091-3057(03)00221-1 1:CAS:528:DC%2BD3sXosVylu74%3D 14592676 (Pubitemid 37336556)
18. A Hayashi M Suzuki M Sasamata K Miyata 2005 Agonist diversity in 5-HT(2C) receptor-mediated weight control in rats Psychopharmacology (Berl) 178 241 249 10.1007/s00213-004-2019-z 1:CAS:528:DC%2BD2MXhsVKru7g%3D (Pubitemid 40379219)
19. L Hernandez BG Hoebel 1988 Feeding and hypothalamic stimulation increase dopamine turnover in the accumbens Physiol Behav 44 599 606 10.1016/0031- 9384(88)90324-1 1:CAS:528:DyaL1MXmvFyqsg%3D%3D 3237847 (Pubitemid 19030123)
20. K Herrick-Davis E Grinde M Teitler 2000 Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors J Pharmacol Exp Ther 295 226 232 1:CAS:528:DC%2BD3cXnt1ygu7w%3D 10991983
21. HC Jackson MC Bearham LJ Hutchins SE Mazurkiewicz AM Needham DJ Heal 1997 Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat Br J Pharmacol 121 1613 1618 10.1038/sj.bjp.0701311 1:CAS:528:DyaK2sXlslaqt70%3D 9283694 (Pubitemid 27343387)
22. M Kalinichev C Rourke AJ Daniels MK Grizzle CS Britt DM Ignar DN Jones 2005 Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats Psychopharmacology (Berl) 182 220 231 10.1007/s00213-005-0081-9 1:CAS:528:DC%2BD2MXhtFahtLfJ (Pubitemid 41464615)
23. GA Kennett MD Wood F Bright B Trail G Riley V Holland KY Avenell T Stean N Upton S Bromidge IT Forbes AM Brown DN Middlemiss TP Blackburn 1997 SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist Neuropharmacology 36 609 620 10.1016/S0028-3908(97)00038-5 1:CAS:528:DyaK2sXktlSmu7Y%3D 9225286 (Pubitemid 27272106)
24. SL Kirk JC Neill DN Jones GP Reynolds 2004 Ziprasidone suppresses olanzapine-induced increases in ingestive behaviour in the rat Eur J Pharmacol 505 253 254 10.1016/j.ejphar.2004.10.015 1:CAS:528:DC%2BD2cXhtVWjsb7K 15556160 (Pubitemid 39535699)
25. WK Kroeze SJ Hufeisen BA Popadak SM Renock S Steinberg P Ernsberger K Jayathilake HY Meltzer BL Roth 2003 H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs Neuropsychopharmacology 28 519 526 10.1038/sj.npp.1300027 1:CAS:528: DC%2BD3sXhslyjt7Y%3D 12629531
26. A Lecklin L Tuomisto 1998 The blockade of H1 receptors attenuates the suppression of feeding and diuresis induced by inhibition of histamine catabolism Pharmacol Biochem Behav 59 753 758 10.1016/S0091-3057(97)00465-6 1:CAS:528:DyaK1cXhs1amu7o%3D 9512082 (Pubitemid 28144220)
27. P Martel M Fantino 1996 Mesolimbic dopaminergic system activity as a function of food reward: a microdialysis study Pharmacol Biochem Behav 53 221 226 10.1016/0091-3057(95)00187-5 1:CAS:528:DyaK28XhtVykug%3D%3D 8848454 (Pubitemid 26117745)
28. A Matsui-Sakata H Ohtani Y Sawada 2005 Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus Drug Metab Pharmacokinet 20 368 378 10.2133/dmpk.20.368 1:CAS:528:DC%2BD2MXhtleksb%2FF 16272755
29. J Minet-Ringuet PC Even M Goubern D Tomé R de Beaurepaire 2006 Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration Appetite 46 254 262 10.1016/j.appet.2006.01.008 1:CAS:528: DC%2BD28XlvFGis70%3D 16551485 (Pubitemid 43867820)
30. L Rauser JE Savage HY Meltzer BL Roth 2001 Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor J Pharmacol Exp Ther 299 83 89 1:CAS:528:DC%2BD3MXntFWltrY%3D 11561066
31. GP Reynolds 2004 Receptor mechanisms in the treatment of schizophrenia J Psychopharmacol 18 340 345 10.1177/026988110401800303 1:CAS:528: DC%2BD2cXpsl2nu7o%3D 15358977 (Pubitemid 39382562)
32. T Sakata K Ookuma K Fukagawa K Fujimoto H Yoshimatsu T Shiraishi H Wada 1988 Blockade of the histamine H1-receptor in the rat ventromedial hypothalamus and feeding elicitation Brain Res 441 403 407 10.1016/0006-8993(88)91423-0 1:CAS:528:DyaL1cXht1Gis7s%3D 3359243 (Pubitemid 18059993)
33. A Schotte PF Janssen W Gommeren WH Luyten P Van Gompel AS Lesage K De Loore JE Leysen 1996 Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding Psychopharmacology (Berl) 124 57 73 10.1007/BF02245606 1:CAS:528:DyaK28XjsFGktLk%3D (Pubitemid 26112775)
34. S Snigdha C Thumbi GP Reynolds JC Neill 2008 Ziprasidone and aripiprazole attenuate olanzapine-induced hyperphagia in rats J Psychopharmacol 22 567 71 10.1177/0269881107081519 1:CAS:528:DC%2BD1cXhtFensL3O 18208914
35. GJ Wang ND Volkow J Logan NR Pappas CT Wong W Zhu N Netusil JS Fowler 2001 Brain dopamine and obesity Lancet 357 354 357 10.1016/S0140-6736(00)03643-6 1:CAS:528:DC%2BD3MXhtFaktr4%3D 11210998 (Pubitemid 32128542)
36. T Wetterling 2001 Bodyweight gain with atypical antipsychotics. A comparative review Drug Saf 24 59 73 10.2165/00002018-200124010-00005 1:CAS:528:DC%2BD3MXhsVWqsrY%3D 11219487
37. DA Wirshing WC Wirshing L Kysar MA Berisford D Goldstein J Pashdag J Mintz SR Marder 1999 Novel antipsychotics: comparison of weight gain liabilities J Clin Psychiatry 60 358 363 1:CAS:528:DyaK1MXktlegsLY%3D 10401912
38. MD Wood C Reavill B Trail A Wilson T Stean GA Kennett S Lightowler TP Blackburn D Thomas TL Gager G Riley V Holland SM Bromidge IT Forbes DN Middlemiss 2001 SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety Neuropharmacology 41 186 199 10.1016/S0028-3908(01)00054-5 1:CAS:528: DC%2BD3MXlslersr4%3D 11489455 (Pubitemid 32728090)